Skip to main content
Clinical Trials/ISRCTN10993769
ISRCTN10993769Completed未知

Maxillary sinus augmentation with A-RRF and serum albumin-coated allograft- prospective randomized trial for the determination of the optimal healing time for dental implant loading

Semmelweis University Doctoral School of Clinical Medicine0 sites30 target enrollmentStarted: October 16, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

2021 Results article in https://doi.org/10.3390/ma14071810 (added 15/04/2021)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Systemically healthy patients aged over 18 years
  • 2. Requiring implant prostheses and oral rehabilitation
  • 3. Insufficient residual height in posterior maxilla requiring a sinus augmentation from lateral approach to insert the implants (residual crest height =5 mm)

Exclusion Criteria

  • 1. Current pregnancy or intention to become pregnant during the study follow-up period
  • 2. Sinusitis
  • 3. Smoking
  • 4. Alcoholism
  • 5. Severe haematological disorder or disease
  • 6. History of chronic hepatitis or liver cirrhosis
  • 7. Diabetes mellitus with poor metabolic control
  • 8. Receiving dialysis
  • 9. Metabolic bone disease
  • 10. Taking bisphosphonates drugs whether orally or intravenously
  • 11. Undergoing or having received radiotherapy, chemotherapy or immunosuppressive therapy
  • 12. Any other inability to participate in the study

Investigators

Sponsor
Semmelweis University Doctoral School of Clinical Medicine

Similar Trials